M-ESLON® (retard release morphine sulphate capsules) for pain control in cancer patients

Pathology & Oncology Research

Attila J Horváth¹  Tünde Gáspár¹  Lajos Bognár¹  Miklñs Tekeres¹  Anita Szabó¹ 

[1] University of Medieine$$

关键词: side effects;   

DOI  :  10.1007/BF02904818

学科分类：生理学与病理学

来源: Springer

【 摘 要 】

The pain of patients who were in the terminal phase of advanced malignant tumors was successfully relieved by M-ESLON® capsules of controlled release morphine sulphate (10-30-60-100 mg). The most frequent side effects (sickness, vomiting, obstipation) were effectively controlled. The concentration of the drug in the plasma was stable, therefore the lasting pain relief was ensured.

【 授权许可】

Unknown